B O O K - American College of Rheumatology

• compare the prevalence and epidemiology of SpA in a
population-based questionnaire study from Mexico
A402
Genetics of Autoimmune Rheumatic Diseases in Latin
America
Moderator: Juan-Manuel Anaya, MD; CIB-Rosario University;
Medellin, Colombia
6:45 PM
Admixture and Diversity in Latin America
Maurico Arcos-Burgos, MD, PhD; University of Miami; Miami, FL
7:10 PM
Genetics of Rheumatoid Arthritis in Latin Americans
Angelica M. Delgado-Vega, MD; Uppsala University, Sweden
7:30 PM
Genetics of Systemic Lupus Erythematosus in Latin Americans:
Its Impact on ITGAM Association and Implications for
Admixture Mapping in SLE
Swapan K. Nath, PhD; Oklahoma Medical Research Foundation;
Oklahoma City, OK
7:50 PM
The Common Autoimmunity Genes in Latin Americans
Juan-Manuel Anaya, MD; CIB-Rosario University; Medellin,
Colombia
Session Overview:
Autoimmune rheumatic diseases are complex traits in which
both genetic and environmental factors are incriminated
in their etiopathogenesis. The expression of these diseases
varies depending upon ethnicity and geography. The large and
diverse population of Latin America is a powerful resource for
elucidating the genetic basis of these complex traits.
Upon completion of this session, participants should be able to:
• learn about the genetic landscape of Latin America and the
genetic susceptibility of autoimmune rheumatic diseases in
this population.
A316
Geriatric Rheumatology
Moderators: Yuri R. Nakasato, MD, MBA; University of North
Dakota; Fargo, ND
Raymond L. Yung, MD; University of Michigan; Ann Arbor, MI
6:45 PM
Does Frailty in Old Age Amplify Glucocorticoid Toxicity?
Eswar Krishnan, MD; Stanford University; Palo Alto, CA
7:10 PM
Use of DMARDs and Biological Therapy in the Older Population
Richard Brasington, MD; Washington University School of
Medicine; St. Louis, MO
7:35 PM
Ideal Rheumatology Practice for the Older Patient
Yuri R. Nakasato, MD, MBA; MeritCare/University of North
Dakota; Fargo, ND
Session Overview:
Rheumatology faces an increasingly older, frail and complex
population. The current structure is not prepared to sustain this
challenge. Older patients have atypical presentations of common
rheumatic conditions and diseases that may be the result of
the process of aging or associated with it. There is a higher life
expectancy, but a higher morbidity and disability, most of them
related to arthritis. Rheumatology struggles between improving
quality of life versus not causing harmful side effects due to
medications. Innovation of care, research, education and health
policy of the older adult is critical to the future of rheumatology.
Upon completion of this session, participants should be able to:
• describe the phenomenon of frailty, how it differs from
disability and increases propensity to drug toxicity in the
elderly
• distinguish important considerations in the management of
older patients with Disease Modifying Antirheumatic Drugs
and biological therapy
• analyze features of an ideal rheumatology practice for the
older patient
B409
Global Musculoskeletal Health Initiatives
Moderators: Lyn March, MD; University of Sydney Medical
School; Sydney, Australia
Anthony Woolf, MBBS; Royal Cornwall Hospital; Truro Cornwall,
United Kingdom
Richard H. Osborne, PhD; Deakin University; Melbourne,
Australia
Sherine E. Gabriel, MD, MSc; Mayo Clinic; Rochester, MN
Peter Tugwe, MD; Institute of Population Health; Ottawa, ON,
Canada
6:45 PM
Global Prevalence and Treatment of RA - Identifying Knowledge
Gaps
Marita Cross, MPH, PhD; Institute of Bone and Joint Research,
University of Sydney; St. Leonards, NSW, Australia
7:00 PM
Global Bone Density and Osteoporotic Fracture Risk -
Identifying Regional Variations for Priority Setting
Lidia Sanchez-Riera, MD; Institute of Bone and Joint Research,
University of Sydney; St. Leonards, NSW, Australia
7:15 PM
Other MSK Disorders - Towards Better Definitions and
Representations
Emma Smith, MSc(Phty), PhD; Institute of Bone and Joint
Research, University of Sydney; St. Leonards, Australia
7:30 PM
Bridging the Knowledge Gaps - Strategies for Developing
Consensus for Standardised Population-based Measurment of
MSK Conditions
Anthony D. Woolf, MBBS; Royal Cornwall Hospital; Truro
Cornwall, United Kingdom
7:45 PM
Beyond the Burden - Strategies for Identifying Global Inequity
in Access to Evidence-Based MSK Health Care
To be announced
Session Overview:
Much data are being collated across many countries in support
of the Global Burden of Disease, Injuries and Risk Factors study.
tuesday
2010 Program Book 89